Earnings Reportpositive

Earnings Report

Other upcoming events for KRYS

Phase 3 ReadoutPhase 3 Topline: A Double-Blind Crossover of KB803 and Matched Placebo for the Treatment and Prevention of Corneal Ab

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — KRYS Earnings Report | BioSniper